Clearpoint Neuro is trading 5.5% down at $9.11 in after-hours trading, and the reason for the decline remains unclear. - Shares closed at $9.64 in the October 15 regular session. - No company-specific announcement explaining the move was identified for October 15; the company’s latest release scheduled third-quarter results for October 28. - Major indexes finished higher, and no verified after-hours catalyst or trading-volume information was found.